STEEPLE: Difference between revisions
Jump to navigation
Jump to search
(STEEPLE moved to STEEPLE bleeding criteria) |
Rim Halaby (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | |||
==Overview== | |||
STEEPLE refers to the Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation trial. | |||
[[STEEPLE bleeding criteria|Click here for STEEPLE bleeding criteria]] | |||
[[Category:Cardiology]] | |||
[[Category:Clinical research]] | |||
[[Category:Clinical trials]] | |||
Latest revision as of 16:52, 22 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
STEEPLE refers to the Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation trial.